Skip to main content
Premium Trial:

Request an Annual Quote

Forensic Genomics Firm Othram Raises $18M in Series B Round

NEW YORK — Forensic genomics company Othram said last week that it has raised $18 million in a Series B financing round led by Gigafund.

Othram combines DNA sequencing from degraded or low-input source material with advanced human identification applications. It has been working with academic researchers, forensic scientists, medical examiners, and law enforcement agencies on unsolved crimes. The Woodlands, Texas-based company said it will use the new funding to continue development of its genetic testing technology and expand its operations throughout North America.

"The family and friends of victims will not be around forever, and once they are gone then the opportunity to do right by them is lost," Othram CEO David Mittelman said in a statement. "We have technology that can bring answers and we need to make this technology available for all cases."

In 2019, Othram raised $4 million in Series A funding and was awarded a $10,000 research sequencing grant from Illumina Accelerator.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.